CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.

Source:http://linkedlifedata.com/resource/pubmed/id/20197461

Cancer Res. 2010 Mar 15 70 6 2455-64

Download in:

View as

General Info

PMID
20197461